{"count": 4, "results": [{"_id": "25837018", "pmid": 25837018, "title": "Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure.", "journal": "Heart Lung Circ", "authors": ["Brower GL", "Levick SP", "Janicki JS"], "date": "2015-09-01T00:00:00Z", "doi": "10.1016/j.hlc.2015.02.023", "meta_date_publication": "2015 Sep", "meta_volume": "24", "meta_issue": "9", "meta_pages": "919-24", "score": 50075.02, "text_hl": "BACKGROUND: Angiotensin converting enzyme (ACE) inhibitors such as @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, represent the front line pharmacological treatment for @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@, which is characterised by marked @<m>DISEASE_Cardiomyopathy_Dilated_with_Left_Ventricular_Noncompaction</m> @DISEASE_MESH:C565277 @@@left ventricular (LV) dilatation@@@ and @DISEASE_Hypertrophy @DISEASE_MESH:D006984 @@@hypertrophy@@@. ", "citations": {"NLM": "Brower GL, Levick SP, Janicki JS. Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure. Heart Lung Circ. 2015 Sep;24(9):919-24. PMID: 25837018", "BibTeX": "@article{25837018, title={Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure.}, author={Brower GL and Levick SP and Janicki JS}, journal={Heart Lung Circ}, volume={24}, number={9}, pages={919-24}}"}}, {"_id": "8922912", "pmid": 8922912, "title": "The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.", "journal": "Eur Heart J", "authors": ["Nicolosi GL", "Latini R", "Marino P", "Maggioni AP", "Barlera S", "Franzosi MG", "Geraci E", "Santoro L", "Tavazzi L", "Tognoni G", "Vecchio C", "Volpi A"], "date": "1996-11-01T00:00:00Z", "doi": "10.1093/oxfordjournals.eurheartj.a014747", "meta_date_publication": "1996 Nov", "meta_volume": "17", "meta_issue": "11", "meta_pages": "1646-56", "score": 50072.44, "text_hl": "We assessed (1) the prognostic value of pre-discharge 2-D echocardiographic variables, and (2) the effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on the progression of @<m>DISEASE_Cardiomyopathy_Dilated_with_Left_Ventricular_Noncompaction</m> @DISEASE_MESH:C565277 @@@left ventricular dilatation@@@. ", "citations": {"NLM": "Nicolosi GL, Latini R, Marino P, Maggioni AP, Barlera S, Franzosi MG, Geraci E, Santoro L, Tavazzi L, Tognoni G, Vecchio C, Volpi A. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Eur Heart J. 1996 Nov;17(11):1646-56. PMID: 8922912", "BibTeX": "@article{8922912, title={The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.}, author={Nicolosi GL and Latini R and Marino P and Maggioni AP and Barlera S and Franzosi MG and Geraci E and Santoro L and Tavazzi L and Tognoni G and Vecchio C and Volpi A}, journal={Eur Heart J}, volume={17}, number={11}, pages={1646-56}}"}}, {"_id": "17308006", "pmid": 17308006, "title": "Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.", "journal": "Am J Physiol Heart Circ Physiol", "authors": ["Brower GL", "Levick SP", "Janicki JS"], "date": "2007-06-01T00:00:00Z", "doi": "10.1152/ajpheart.00447.2006", "meta_date_publication": "2007 Jun", "meta_volume": "292", "meta_issue": "6", "meta_pages": "H3057-64", "score": 50064.64, "text_hl": "Long-term in vivo administration of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ also prevented @<m>DISEASE_Cardiomyopathy_Dilated_with_Left_Ventricular_Noncompaction</m> @DISEASE_MESH:C565277 @@@LV dilatation@@@, attenuated @DISEASE_Hypertrophy @DISEASE_MESH:D006984 @@@myocardial hypertrophy@@@, and prevented changes in myocardial compliance and contractility. ", "citations": {"NLM": "Brower GL, Levick SP, Janicki JS. Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3057-64. PMID: 17308006", "BibTeX": "@article{17308006, title={Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.}, author={Brower GL and Levick SP and Janicki JS}, journal={Am J Physiol Heart Circ Physiol}, volume={292}, number={6}, pages={H3057-64}}"}}, {"_id": "29960964", "pmid": 29960964, "title": "Reversible cardiac dysfunction in long-standing hypertension may be global variant of stress cardiomyopathy.", "journal": "BMJ Case Rep", "authors": ["Chockalingam A", "Kumar SA"], "date": "2018-06-29T00:00:00Z", "doi": "10.1136/bcr-2018-225044", "meta_date_publication": "2018 Jun 29", "meta_volume": "2018", "meta_issue": "", "meta_pages": "", "score": 50052.586, "text_hl": "He responded well to diuretics and gradual uptitration of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@carvedilol@@@. ", "citations": {"NLM": "Chockalingam A, Kumar SA. Reversible cardiac dysfunction in long-standing hypertension may be global variant of stress cardiomyopathy. BMJ Case Rep. 2018 Jun 29;2018():. PMID: 29960964", "BibTeX": "@article{29960964, title={Reversible cardiac dysfunction in long-standing hypertension may be global variant of stress cardiomyopathy.}, author={Chockalingam A and Kumar SA}, journal={BMJ Case Rep}, volume={2018}}"}}]}